Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LYL273
i
Other names:
LYL273, GCC19CART, gucy2c CAR-T cells, gucy2c cart cells, ICTCAR-CRC, LYL 273, LYL-273
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Innovative Cellular Therapeutics, Lyell Immunopharma
Drug class:
GUCY2C-targeted CAR-T immunotherapy
Related drugs:
‹
IM96 CAR-T cells (1)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
Mesothelin/GPC3/GUCY2C-CAR-T (0)
XKDCT080 (0)
IM96 CAR-T cells (1)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
Mesothelin/GPC3/GUCY2C-CAR-T (0)
XKDCT080 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Colorectal Cancer
No biomarker
Colorectal Cancer
LYL273
Sensitive: B - Late Trials
LYL273
Sensitive
:
B
LYL273
Sensitive: B - Late Trials
LYL273
Sensitive
:
B
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.